StockData
Coya Therapeutics, Inc. logo

Coya Therapeutics, Inc. (COYA) stock

COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3017% above fair value
$3.02+0.02 (+0.67%)

Close on Nov 17, 2026Market cap $70.84MP/E –Yield –

Coya Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Coya Therapeutics's total assets was $39.32M at Sep 30, 2026. For fiscal 2025 it was $49.95M, up 12.6% from the year before. The highest annual figure on record is $49.95M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$49.95M+12.6%
FY2024Dec 31, 2024$44.35M+7.5%
FY2023Dec 31, 2023$41.26M+391.5%
FY2022Dec 31, 2022$8.40M+75.2%
FY2021Dec 31, 2021$4.79M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$39.32M+22.7%
Q2 FY2026Jun 30, 2026$47.31M+41.4%
Q1 FY2026Mar 31, 2026$53.27M+38.7%
Q4 FY2025Dec 31, 2025$49.95M+12.6%
Q3 FY2025Sep 30, 2025$32.04M-9.9%
Q2 FY2025Jun 30, 2025$33.45M-16.2%
Q1 FY2025Mar 31, 2025$38.40M+2.7%
Q4 FY2024Dec 31, 2024$44.35M+7.5%
Q3 FY2024Sep 30, 2024$35.55M+198.9%
Q2 FY2024Jun 30, 2024$39.94M+176.0%
Q1 FY2024Mar 31, 2024$37.39M+114.7%
Q4 FY2023Dec 31, 2023$41.26M+391.5%
Q3 FY2023Sep 30, 2023$11.90M+148.2%
Q2 FY2023Jun 30, 2023$14.47M–
Q1 FY2023Mar 31, 2023$17.42M–
Q4 FY2022Dec 31, 2022$8.40M–
Q4 FY2021Dec 31, 2021$4.79M–

More Coya Therapeutics figures

See a number that looks wrong?